Eiasi files market authorization for Alzheimer’s drug in JapanïżŒ
Eiasi Co., a Japanese pharmaceutical company, has submitted a marketing authorization application for a drug, lacanemab, to treat Alzheimer's disease.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Eiasi Co., a Japanese pharmaceutical company, has submitted a marketing authorization application for a drug, lacanemab, to treat Alzheimer's disease.
Indian drug major Sun Pharmaceuticalâs western Indian facility of Halal has been issued a warning letter by the FDA for not conforming to Current Good.
The FDA has granted accelerated approval for an intravenous drug to treat Alzheimer's Disease, according to a statement.
Aurobindo Pharma announced that its fully-owned subsidiary, Eugia Pharma Specialities, received final approval from FDA to make and market Azacitidine injection for cancer.
FDA amends Plan B contraceptive pill label to state that it does not harm a fertilized egg and is not an abortion drug
Roche's Actemra is the first FDA-approved monoclonal antibody to treat COVID-19
Philips says its independent tests on recalled respiratory devices found limited health risks for users.
The FDA approved Adstiladrin (nadofaragene firadenovec-vncg), a non-replicating adenoviral vector-based gene therapy for the treatment of high-risk bladder cancer.
Indian drugmaker Sun Pharmaceutical Industries, facility in western Gujarat state, has been listed by the Food & Drug Administration under "import alert," according.
Alembic Pharmaceuticals, an Indian maker of generic drugs, has received FDA approval for diclofenac medicine used to treat osteoarthritis of the knees.